Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Abbott Laboratories

Market Cap 153B 134B 124B 115B 217B 14,457B 218B 1,469B 572B 7,108B 574B 562B 24,693B P/E 2026 *
22.1x
P/E 2027 * 18.9x
Enterprise Value 165B 144B 133B 124B 233B 15,565B 235B 1,582B 616B 7,653B 618B 605B 26,586B EV / Sales 2026 *
3.28x
EV / Sales 2027 * 2.95x
Free-Float
86.73%
Yield 2026 *
2.9%
Yield 2027 * 3.09%
1 day-0.66%
1 week-0.95%
Current month+2.61%
1 month+0.48%
3 months-16.72%
6 months-29.85%
Current year-29.90%
1 week 87.21
Extreme 87.21
91.58
1 month 84.96
Extreme 84.96
92.73
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
139.06
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 36.76
Extreme 36.76
142.6
Manager TitleAgeSince
Chief Executive Officer 52 2020-03-30
Director of Finance/CFO 53 2023-08-31
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 2011-12-08
Director/Board Member 67 2011-12-08
Director/Board Member 71 2017-02-15
Date Insider Type Main position Quantity % Market Cap.
Apr. 27Other

Head of Human Resources

5,314 0.0003%
Apr. 23Free

Director

2,286 0.0001%
Apr. 23Free

Director

2,286 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-0.66%-0.95%-33.96%-18.86% 153B
-0.09%-1.38%-8.19%-9.31% 101B
-1.82%-2.14%+55.70%+57.60% 55.9B
-0.20%-3.61%-7.62%+44.40% 52.78B
-2.27%-3.31%-16.45%-45.48% 38.77B
-3.42%-7.02% - - 29.35B
-4.69%-6.94%-13.66%-45.41% 26.65B
+0.54%-0.52%+52.77%-10.57% 23.29B
-2.25%-1.17%-17.98%-3.98% 20.51B
-1.09%-2.69%-14.97%-5.57% 19.53B
Average -1.60%-2.40%-0.48%-4.13% 52.12B
Weighted average by Cap. -1.13%-1.81%-7.62%-3.41%

Financials

2026 *2027 *
Net sales 50.29B 43.94B 40.65B 37.94B 71.22B 4,752B 71.74B 483B 188B 2,337B 189B 185B 8,117B 54.79B 47.88B 44.29B 41.34B 77.6B 5,178B 78.17B 526B 205B 2,546B 206B 201B 8,844B
Net income 7.02B 6.13B 5.67B 5.29B 9.94B 663B 10.01B 67.41B 26.23B 326B 26.35B 25.78B 1,133B 8.39B 7.33B 6.78B 6.33B 11.89B 793B 11.97B 80.61B 31.36B 390B 31.51B 30.83B 1,355B
Net Debt 11.73B 10.25B 9.48B 8.85B 16.61B 1,108B 16.73B 113B 43.82B 545B 44.03B 43.07B 1,893B 8.88B 7.76B 7.18B 6.7B 12.58B 839B 12.67B 85.32B 33.2B 413B 33.35B 32.63B 1,434B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
26-06-22 $87.83 -0.66% 11,458,235
26-06-18 $88.41 -0.10% 41,964,841
26-06-17 $88.50 -2.34% 13,052,998
26-06-16 $90.62 +2.20% 12,740,746
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
87.83USD
Average target price
116.54USD
Spread / Average Target
+32.69%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!